ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989

Also NCI requests $6.2 billion in FY2005 Bypass Budget.

January 2, 2004

Assurances On Methods For Misconduct Reporting Required

December 1, 1989

Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease

August 30, 2013

DCCP Board Okays Concepts Of New Grants Totaling $1.4 Million Year

February 18, 1983

Senate Appropriations Committee Earmarks $118 Million for Centers, Orders Full Grant Funding

October 9, 1987